Fibotran 500mg Tablet
By Fibotran
Rx
10 Tablet in a Strip

Composition
Tranexamic Acid(500mg)

Manufacturer - Kivi Labs Ltd
Khasra No. 169 Tanshipur Roorkee (U.K)

Expires on or after
July, 2025

liver
Fibotran 500mg Tablet appears to be safe for individuals with liver disease based on the limited data available. It is suggested that liver disease patients might not require a dosage adjustment when using Fibotran 500mg Tablet. It is important to consult your doctor to ensure the appropriate usage of this medication in relation to liver health.

kidney
Fibotran 500mg Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
When taking Fibotran 500mg Tablet, be cautious as it can lead to increased drowsiness when consumed with alcohol.

driving
Fibotran 500mg Tablet generally does not impact your driving ability.

pregnancy
Fibotran 500mg Tablet is considered safe during pregnancy based on animal studies showing no significant adverse effects, although human studies are limited.

breastfeeding
Fibotran 500mg Tablet is considered safe while breastfeeding. Limited data indicates no significant risk to the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | BLOOD RELATED |
Action Class | Antifibrinolytic |
₹174.34
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024